SHANNON COLIN 4

Accession 0001104659-21-083604

CIK 0001613859other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:25 PM ET

Size

33.0 KB

Accession

0001104659-21-083604

Insider Transaction Report

Form 4

Period: 2021-06-17

PRA Health Sciences, Inc.PRAH

SHANNON COLIN

DirectorPresident & CEO

Transactions

Exercise/Conversion
Common Stock
2021-06-17$95.94/sh+31,000$2,974,140→ 420,087 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−91,000→ 39,000 total
Exercise: $75.81Exp: 2027-08-29→ Common Stock (91,000 underlying)
Sale
Common Stock
2021-06-17$169.00/sh−220,195$37,212,955→ 114,400 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−31,000→ 62,000 total
Exercise: $95.94Exp: 2029-08-13→ Common Stock (31,000 underlying)
Exercise/Conversion
Common Stock
2021-06-17$11.73/sh+77,425$908,195→ 132,051 total
Exercise/Conversion
Common Stock
2021-06-17$75.81/sh+91,000$6,898,710→ 389,087 total
Exercise/Conversion
Common Stock
2021-06-17$103.30/sh+31,780$3,282,874→ 496,867 total
Sale
Common Stock
2021-06-17$166.89/sh−920$153,539→ 495,947 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−77,425→ 0 total
Exercise: $11.73From: 2016-11-16Exp: 2023-12-20→ Common Stock (77,425 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−45,000→ 45,000 total
Exercise: $102.44Exp: 2028-08-16→ Common Stock (45,000 underlying)
Exercise/Conversion
Common Stock
2021-06-17$11.73/sh+166,036$1,947,602→ 298,087 total
Exercise/Conversion
Common Stock
2021-06-17$102.44/sh+45,000$4,609,800→ 465,087 total
Sale
Common Stock
2021-06-17$168.13/sh−161,352$27,128,112→ 334,595 total
Sale
Common Stock
2021-06-17$169.63/sh−59,774$10,139,464→ 54,626 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−31,780→ 63,560 total
Exercise: $103.30Exp: 2030-06-01→ Common Stock (31,780 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−166,036→ 0 total
Exercise: $11.73Exp: 2023-12-20→ Common Stock (166,036 underlying)

Footnotes (10)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F10]The option vests in three equal annual installments of 31,780 beginning on June 1, 2021.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.43 to $167.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.53 to $168.525, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.53 to $169.52, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.53 to $169.87, inclusive.
[F6]The option vested in five equal annual installments, commencing on September 23, 2014
[F7]The option vests in four annual installments, commencing on August 29, 2018 at 20% of the grant in the first two years and 30% of the grant in the remaining two years thereafter.
[F8]The option vests in three equal annual installments of 31,000 beginning on August 13, 2020.
[F9]The option vests in four equal annual installments of 22,500 beginning on August 16, 2019.

Documents

1 file

4
tm2120078-4_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PRA Health Sciences, Inc.

CIK 0001613859

→

Entity typeother

Related Parties

filerCIK 0001285101

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 5:25 PM ET
Size: 33.0 KB

View on SEC.gov